Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis

被引:8
|
作者
Bryant, Robert, V [1 ,2 ,3 ]
Day, Alice S. [1 ,2 ]
McGrath, Ken C. [4 ]
Telfer, Karmen [1 ,2 ]
Yao, Chu K. [5 ]
Costello, Samuel P. [1 ,2 ,3 ]
机构
[1] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, IBD Serv, 28 Woodville Rd,Woodville South, Adelaide, SA 5022, Australia
[2] Univ Adelaide, Sch Med, Fac Hlth Sci, Adelaide, SA, Australia
[3] Biomebank, Thebarton, SA, Australia
[4] Microba, Brisbane, Qld, Australia
[5] Monash Univ, Alfred Hosp, Translat Nutrit Sci, Dept Gastroenterol, Melbourne, Vic, Australia
来源
JGH OPEN | 2021年 / 5卷 / 09期
关键词
diet; fecal microbiota transplantation; metagenomics; refractory ulcerative colitis;
D O I
10.1002/jgh3.12623
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fecal microbiota transplantation (FMT) is effective for induction of remission in ulcerative colitis (UC). Diet has potential to augment the efficacy and durability of FMT by encouraging engraftment of transplanted microorganisms. A trial of FMT combined with a defined diet was undertaken as salvage therapy for a 71-year-old woman with active steroid-refractory extensive UC. A multidimensional sulfide-reducing diet (4-SURE diet) was commenced followed by single-donor FMT administered by colonoscopy and then enemas over 7 days. Dietary adherence, clinical evaluation, and stool samples for metagenomic profiling were undertaken at weeks 0, 4, 8, and 24. Colonoscopy was performed 8 weeks post-FMT. Shotgun metagenomic profiling of the donor fecal suspension was also performed. A rapid clinical response to FMT and 4-SURE diet was observed with normalization of stool frequency (<= 2 motions/day) and resolution of rectal bleeding within 2 weeks. Dietary adherence was excellent. Colonoscopy at week 8 revealed no evidence of active colitis (Mayo endoscopic sub-score 0) with histology showing no evidence of acute or chronic lamina propria inflammatory cell infiltrate. Sustained clinical and endoscopic remission out to 24 weeks was observed. Metagenomic sequencing confirmed sustained engraftment of beneficial donor microbiota with increased alpha-diversity and capacity for short-chain fatty acid production, including Faecalibacterium prauznitzii and Eubacterium hallii. This case report supports the rationale of prescribed diet therapy to support engraftment of donor microbiota following FMT for UC. Further large trials with a diet-arm control group are needed to evaluate FMT augmented by a defined diet in UC.
引用
收藏
页码:1099 / 1102
页数:4
相关论文
共 50 条
  • [21] Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis A Systematic Review and Meta-Analysis
    Sun, Dali
    Li, Weiming
    Li, Shumin
    Cen, Yunyun
    Xu, Qingwen
    Li, Yijun
    Sun, Yanbo
    Qi, Yuxing
    Lin, Yueying
    Yang, Ting
    Xu, Pengyuan
    Lu, Qiping
    MEDICINE, 2016, 95 (23)
  • [22] Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
    Narula, Neeraj
    Kassam, Zain
    Yuan, Yuhong
    Colombel, Jean-Frederic
    Ponsioen, Cyriel
    Reinisch, Walter
    Moayyedi, Paul
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1702 - 1709
  • [23] An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis
    Huang, Taobi
    Xu, Jinlan
    Wang, Maoying
    Pu, Ke
    Li, Longquan
    Zhang, Huiyun
    Liang, Yuan
    Sun, Weiming
    Wang, Yuping
    MEDICINE, 2022, 101 (30) : E29790
  • [24] Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for Refractory Mild to Moderate Active Ulcerative Colitis: The CRAFT UC randomized controlled trial
    Levine, A.
    Scaldaferri, F.
    Shabat, C. Sarbagili
    Zittan, E.
    Hirsch, A.
    Mentelia, M. C.
    Musca, T.
    Cohen, N. A.
    Ron, Y.
    Isakovc, N. Fliss
    Pfeffer, J.
    Yaakovl, M.
    Fanali, C.
    Turchini, L.
    Masucci, L.
    Quaranta, G.
    Anastasial, G.
    Weinbergera, A.
    Kopylov, U.
    Maharshak, N.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S001 - S001
  • [25] Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Liu, Xiaolei
    Li, Yan
    Wu, Kaichun
    Shi, Yongquan
    Chen, Min
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [26] Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis
    Feng, Jing
    Chen, Yexin
    Liu, Yan
    Lin, Lin
    Lin, Xiujuan
    Gong, Wenxiu
    Xia, Rongmu
    He, Jianquan
    Sheng, Jianwen
    Cai, Huimei
    Xiao, Chuanxing
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [27] The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis
    Cao, Yantian
    Zhang, Bangjie
    Wu, Yuanyuan
    Wang, Qingzhi
    Wang, Jie
    Shen, Fangfang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [28] Efficacy of Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC): Systematic Review and Meta-Analysis
    Rezapour, Mona
    Ali, Saima
    Gerson, Lauren B.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S64 - S66
  • [29] Predictors of efficacy of fecal microbiota transplantation in patients with ulcerative colitis: A systematic review and meta-analysis
    Al-Abedi, A.
    Zalums, A.
    Leong, R.
    Paramsothy, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 117 - 118
  • [30] Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis
    Keshteli, A. H.
    Millan, B.
    Madsen, K. L.
    MUCOSAL IMMUNOLOGY, 2017, 10 (02) : 565 - 566